276 related articles for article (PubMed ID: 25656846)
1. EWI-2 negatively regulates TGF-β signaling leading to altered melanoma growth and metastasis.
Wang HX; Sharma C; Knoblich K; Granter SR; Hemler ME
Cell Res; 2015 Mar; 25(3):370-85. PubMed ID: 25656846
[TBL] [Abstract][Full Text] [Related]
2. Novel impact of EWI-2, CD9, and CD81 on TGF-β signaling in melanoma.
Wang HX; Hemler ME
Mol Cell Oncol; 2015 Oct; 2(1):. PubMed ID: 26989766
[TBL] [Abstract][Full Text] [Related]
3. EWI-2 regulates alpha3beta1 integrin-dependent cell functions on laminin-5.
Stipp CS; Kolesnikova TV; Hemler ME
J Cell Biol; 2003 Dec; 163(5):1167-77. PubMed ID: 14662754
[TBL] [Abstract][Full Text] [Related]
4. Loss of RAB1B promotes triple-negative breast cancer metastasis by activating TGF-β/SMAD signaling.
Jiang HL; Sun HF; Gao SP; Li LD; Hu X; Wu J; Jin W
Oncotarget; 2015 Jun; 6(18):16352-65. PubMed ID: 25970785
[TBL] [Abstract][Full Text] [Related]
5. Reducing isoform complexity of human tetraspanins by optimized expression in Dictyostelium discoideum enables high-throughput functional read-out.
Scheltz T; von Bülow J; Beitz E
Protein Expr Purif; 2017 Jul; 135():8-15. PubMed ID: 28442431
[TBL] [Abstract][Full Text] [Related]
6. TMEPAI inhibits TGF-β signaling by promoting lysosome degradation of TGF-β receptor and contributes to lung cancer development.
Bai X; Jing L; Li Y; Li Y; Luo S; Wang S; Zhou J; Liu Z; Diao A
Cell Signal; 2014 Sep; 26(9):2030-9. PubMed ID: 24933703
[TBL] [Abstract][Full Text] [Related]
7. Glioblastoma inhibition by cell surface immunoglobulin protein EWI-2, in vitro and in vivo.
Kolesnikova TV; Kazarov AR; Lemieux ME; Lafleur MA; Kesari S; Kung AL; Hemler ME
Neoplasia; 2009 Jan; 11(1):77-86, 4p following 86. PubMed ID: 19107234
[TBL] [Abstract][Full Text] [Related]
8. EWI-2 is a major CD9 and CD81 partner and member of a novel Ig protein subfamily.
Stipp CS; Kolesnikova TV; Hemler ME
J Biol Chem; 2001 Nov; 276(44):40545-54. PubMed ID: 11504738
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal stem cells induce epithelial mesenchymal transition in melanoma by paracrine secretion of transforming growth factor-β.
Lv C; Dai H; Sun M; Zhao H; Wu K; Zhu J; Wang Y; Cao X; Xia Z; Xue C
Melanoma Res; 2017 Apr; 27(2):74-84. PubMed ID: 28079609
[TBL] [Abstract][Full Text] [Related]
10. Osteopontin promotes the invasive growth of melanoma cells by activating integrin αvβ3 and down-regulating tetraspanin CD9.
Yin M; Soikkeli J; Jahkola T; Virolainen S; Saksela O; Hölttä E
Am J Pathol; 2014 Mar; 184(3):842-58. PubMed ID: 24412090
[TBL] [Abstract][Full Text] [Related]
11. Tetraspanin protein contributions to cancer.
Wang HX; Li Q; Sharma C; Knoblich K; Hemler ME
Biochem Soc Trans; 2011 Apr; 39(2):547-52. PubMed ID: 21428937
[TBL] [Abstract][Full Text] [Related]
12. An novel inhibitor of TGF-β type I receptor, IN-1130, blocks breast cancer lung metastasis through inhibition of epithelial-mesenchymal transition.
Park CY; Min KN; Son JY; Park SY; Nam JS; Kim DK; Sheen YY
Cancer Lett; 2014 Aug; 351(1):72-80. PubMed ID: 24887560
[TBL] [Abstract][Full Text] [Related]
13. DRAK2 participates in a negative feedback loop to control TGF-β/Smads signaling by binding to type I TGF-β receptor.
Yang KM; Kim W; Bae E; Gim J; Weist BM; Jung Y; Hyun JS; Hernandez JB; Leem SH; Park T; Jeong J; Walsh CM; Kim SJ
Cell Rep; 2012 Nov; 2(5):1286-99. PubMed ID: 23122956
[TBL] [Abstract][Full Text] [Related]
14. Overexpressed VEPH1 inhibits epithelial-mesenchymal transition, invasion, and migration of human cutaneous melanoma cells through inactivating the TGF-β signaling pathway.
Feng H; Jia XM; Gao NN; Tang H; Huang W; Ning N
Cell Cycle; 2019 Nov; 18(21):2860-2875. PubMed ID: 31599708
[TBL] [Abstract][Full Text] [Related]
15. A specific inhibitor of TGF-beta receptor kinase, SB-431542, as a potent antitumor agent for human cancers.
Halder SK; Beauchamp RD; Datta PK
Neoplasia; 2005 May; 7(5):509-21. PubMed ID: 15967103
[TBL] [Abstract][Full Text] [Related]
16. EWI-2 is a new component of the tetraspanin web in hepatocytes and lymphoid cells.
Charrin S; Le Naour F; Labas V; Billard M; Le Caer JP; Emile JF; Petit MA; Boucheix C; Rubinstein E
Biochem J; 2003 Jul; 373(Pt 2):409-21. PubMed ID: 12708969
[TBL] [Abstract][Full Text] [Related]
17. SPSB1, a Novel Negative Regulator of the Transforming Growth Factor-β Signaling Pathway Targeting the Type II Receptor.
Liu S; Nheu T; Luwor R; Nicholson SE; Zhu HJ
J Biol Chem; 2015 Jul; 290(29):17894-17908. PubMed ID: 26032413
[TBL] [Abstract][Full Text] [Related]
18. LRG1 modulates invasion and migration of glioma cell lines through TGF-β signaling pathway.
Zhong D; He G; Zhao S; Li J; Lang Y; Ye W; Li Y; Jiang C; Li X
Acta Histochem; 2015 Jul; 117(6):551-8. PubMed ID: 26049667
[TBL] [Abstract][Full Text] [Related]
19. Tetraspanins are involved in Schwann cell-axon interaction.
Chernousov MA; Stahl RC; Carey DJ
J Neurosci Res; 2013 Nov; 91(11):1419-28. PubMed ID: 24038174
[TBL] [Abstract][Full Text] [Related]
20. Effects of TGF-β signaling in clear cell renal cell carcinoma cells.
Boström AK; Lindgren D; Johansson ME; Axelson H
Biochem Biophys Res Commun; 2013 May; 435(1):126-33. PubMed ID: 23618868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
